title: Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
authors.affiliation: Merck SA, Alges, Portugal.
authors.forename: N
authors.initials: N
authors.lastname: Silverio
authors.affiliation: Merck SA, Alges, Portugal.
authors.forename: L
authors.initials: L
authors.lastname: Sequeira
authors.affiliation: EMD Serono, rockland, ME, USA.
authors.forename: D
authors.initials: D
authors.lastname: Meletiche